This is a Permanent, Full Time vacancy that will close in {x} days at {xx:xx} BST.
The Vacancy
Funding support from the UK Government, in the form of the CGT Catapult core grant, is a fundamental element of the CGT Catapult operating model. It is essential that CGT Catapult ensures this funding is employed to deliver the optimal impact to our Collaborators, partners, and stakeholders including but not limited to academia, industry, and NHS. CGT Catapult must also, whenever possible, use data-based decisions for development of business cases and its business planning.
The Impact and Business Analyst works with the Chief Strategy and Impact Officer (CSIO) and Senior Impact Manager to understand the nature of Impact that CGT Catapult can deliver. Using a thorough understanding of how the CGT Catapult operating model is configured to deliver this Impact the role develops and manages the data systems used to evidence CGT Catapult performance
In addition, this role will work closely with PMO, Finance, Business Development and the Business Streams to ensure that all activities are appropriate captured and reported to maximise the demonstration of CGT Catapult impact.
Key Accountabilities:
Experience:
Knowledge / Skills / Competencies:
Education / Qualifications
CGT Catapult is committed to providing an equal, diverse, and inclusive work environment where everyone’s contributions are valued. We celebrate differences, empower, and inspire everyone, because when everyone is included, everyone wins. In 2024, we received bronze accreditation from Inclusive Employers.
The Company
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation.
With more than 350 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies.
The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.
Our Benefits
Career Development Opportunities
Discretionary Performance Related Bonus
Generous Annual Leave
Generous Salary Sacrifice Pension Contribution
Interest Free Travel Loan
Cycle to Work Scheme
Life Assurance
Electric Car Scheme
Our Gallery
Documents
Alternatively, please sign in with...
Published
Not PublishedClosing
in X days